Bringing the fundamentals into focus…
Back to Entrada Therapeutics, Inc.
How Entrada Therapeutics, Inc. stacks up
TRDA · against 209 other Healthcare companies of similar size
Overall
33/ 100
Below the middle of the pack.
Ranked #155 of 210 · scores higher than 25% of peers
Bars: peers in each 10-point band of the overall score44 peers with an overall score of 30–39, including TRDA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TRDA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 2 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 2 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 4 | 356M AUD (≈$235M) | 81 | 98 | 35 | 97 | 0 / 2 | |
| 5 | 256M USD | 80 | 98 | 35 | 92 | 0 / 2 | |
| 150 | 223M USD | 34 | 8 | 4 | 28 | 0 / 2 | |
| 150 | 172M USD | 34 | 8 | 96 | 27 | 2 / 2 | |
| 155 | 337M USD | 33 | 0 | — | 12 | 0 / 2 | |
| 155 | 221M USD | 33 | 8 | 62 | 28 | 2 / 2 | |
| 155 | 184M USD | 33 | 33 | 4 | 3 | 0 / 2 | |
| 158 | 357M USD | 32 | 8 | 38 | 8 | 0 / 2 | |
| 158 | 126M USD | 32 | 33 | 84 | 10 | 2 / 2 | |
| 158 | 139M USD | 32 | 8 | 55 | 15 | 1 / 2 | |
| 161 | 1.4B MYR (≈$309M) | 31 | 8 | 18 | 30 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score